Embla Medical hf (OTCPK:OSSFF)
$ 5.1 0 (0%) Market Cap: 2.11 Bil Enterprise Value: 2.57 Bil PE Ratio: 31.48 PB Ratio: 2.87 GF Score: 79/100

Ossur hf Corporate Analyst Meeting Transcript

Mar 30, 2023 / 06:00AM GMT
Release Date Price: $4.9
Niels Jacobsen

Good morning, and welcome, everybody. Welcome to Ãssur Capital Markets Day. My name is Niels Jacobsen. I'm Chairman of Ãssur. I'm CEO of William Demant Invest. And that's the reason for my presence here today.

William Demant Invest have invested in Ãssur since 2004, and the company and the profile and purpose align well with our investment philosophy of owning significant shares in medical device companies that are operating in markets with sustainable favorable growth dynamics. And as you probably know, William Demant Invest is an evergreen investor, meaning that we own our companies on a long-term basis, and we operate our companies not in a way for selling them again. We really think that having this long-term perspective and running the companies in a long-term perspective makes a difference compared to how we see private equity run companies with a view to sale as the main purpose.

Over the last 2 decades, Ãssur have grown consistently through organic growth and acquisitions. The company continues to mature and develop its business model with a goal of improving the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot